Teradyne (TER) Tops Q3 EPS by 11c

Teradyne (NASDAQ: TER) reported Q3 EPS of $1.15, $0.11 better than the analyst estimate of $1.04. Revenue for the quarter came in at $827 million versus the consensus estimate of $802.22 million.

GUIDANCE:

Teradyne sees Q4 2022 EPS of $0.62-$0.86, versus the consensus of $0.72. Teradyne sees Q4 2022 revenue of $670-750 million, versus the consensus of $694.25 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Fluent (FLNT) Tops Q2 EPS by 4c
• DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
• Repay Holdings Corporation (RPAY) Misses Q2 EPS by 36c